NSPR logo

InspireMD, Inc.

NSPR

NSPR: InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

more

Show NSPR Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of NSPR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by NSPR's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Intravascular aneurysm treatment device and methods Jul. 06, 2021
  • Patent Title: Stent assembly and methods for treatment via body lumens Mar. 02, 2021
  • Patent Title: Optimized stent jacket having single fiber mesh Sep. 10, 2019
  • Patent Title: Methods of providing optimized drug-eluting stent assemblies Sep. 10, 2019
  • Patent Title: Deformable tip for stent delivery and methods of use Apr. 16, 2019
  • Patent Title: Knitted stent jackets Nov. 27, 2018
  • Patent Title: Optimized stent jacket Sep. 11, 2018
  • Patent Title: Carotid stent apparatus and methods for treatment via body lumens Aug. 28, 2018
  • Patent Title: Stent-mesh assembly and methods Oct. 10, 2017
  • Patent Title: Stent thermoforming apparatus and methods Oct. 10, 2017
  • Patent Title: Stent thermoforming apparatus and methods Dec. 27, 2016
  • Patent Title: Optimized drug-eluting stent assembly methods Dec. 27, 2016
  • Patent Title: In vivo filter assembly Sep. 15, 2015
  • Patent Title: Optimized drug-eluting stent assembly Sep. 15, 2015
  • Patent Title: Bifurcated stent assemblies Feb. 24, 2015
  • Patent Title: In vivo filter assembly Oct. 25, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NSPR in WallStreetBets Daily Discussion

NSPR News

Recent insights relating to NSPR

CNBC Recommendations

Recent picks made for NSPR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NSPR

Corporate Flights

Flights by private jets registered to NSPR